D-0155-2018 Class II Terminated

Recalled by Solco Healtcare US LLC — Cranbury, NJ

FDA drug recall D-0155-2018 was initiated by Solco Healtcare US LLC on Dec 4, 2017 and is designated Class II. Reason for recall: Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg The recall status is terminated (terminated Feb 25, 2019).

Recall details

Product Type
Drugs
Report Date
Jan 17, 2018
Initiation Date
Dec 4, 2017
Termination Date
Feb 25, 2019
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Gabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: Solco Healthcare US, LLC, Cranbury, NJ, 08512, USA. NDC 43547-0333-50

Reason for recall

Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg

Distribution pattern

Product was distributed in Mason, OH.

Code information

Lot # 7700656A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0155-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0155-2018. Report a data issue: hello@regdatalab.com.